<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35714649</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2214-109X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Lancet. Global health</Title><ISOAbbreviation>Lancet Glob Health</ISOAbbreviation></Journal><ArticleTitle>Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study.</ArticleTitle><Pagination><StartPage>e989</StartPage><EndPage>e1002</EndPage><MedlinePgn>e989-e1002</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2214-109X(22)00174-7</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2214-109X(22)00174-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing a comprehensive state-of-the-art diagnostic procedure harmonised across all centres, and identifying clinical characteristics related to patients' conditions.</AbstractText><AbstractText Label="METHODS">In this multicentre, observational, prospective study of childhood encephalitis, four referral hospitals in Cambodia, Vietnam, Laos, and Myanmar recruited children (aged 28 days to 16 years) who presented with altered mental status lasting more than 24 h and two of the following minor criteria: fever (within the 72 h before or after presentation), one or more generalised or partial seizures (excluding febrile seizures), a new-onset focal neurological deficit, cerebrospinal fluid (CSF) white blood cell count of 5 per mL or higher, or brain imaging (CT or MRI) suggestive of lesions of encephalitis. Comprehensive diagnostic procedures were harmonised across all centres, with first-line testing was done on samples taken at inclusion and results delivered within 24 h of inclusion for main treatable causes of disease and second-line testing was done thereafter for mostly non-treatable causes. An independent expert medical panel reviewed the charts and attribution of causes of all the included children. Using multivariate analyses, we assessed risk factors associated with unfavourable outcomes (ie, severe neurological sequelae and death) at discharge using data from baseline and day 2 after inclusion. This study is registered with ClinicalTrials.gov, NCT04089436, and is now complete.</AbstractText><AbstractText Label="FINDINGS">Between July 28, 2014, and Dec 31, 2017, 664 children with encephalitis were enrolled. Median age was 4·3 years (1·8-8·8), 295 (44%) children were female, and 369 (56%) were male. A confirmed or probable cause of encephalitis was identified in 425 (64%) patients: 216 (33%) of 664 cases were due to Japanese encephalitis virus, 27 (4%) were due to dengue virus, 26 (4%) were due to influenza virus, 24 (4%) were due to herpes simplex virus 1, 18 (3%) were due to Mycobacterium tuberculosis, 17 (3%) were due to Streptococcus pneumoniae, 17 (3%) were due to enterovirus A71, 74 (9%) were due to other pathogens, and six (1%) were due to autoimmune encephalitis. Diagnosis was made within 24 h of admission to hospital for 83 (13%) of 664 children. 119 (18%) children had treatable conditions and 276 (42%) had conditions that could have been preventable by vaccination. At time of discharge, 153 (23%) of 664 children had severe neurological sequelae and 83 (13%) had died. In multivariate analyses, risk factors for unfavourable outcome were diagnosis of M tuberculosis infection upon admission (odds ratio 3·23 [95% CI 1·04-10·03]), coma on day 2 (2·90 [1·78-4·72]), supplementary oxygen requirement (1·89 [1·25-2·86]), and more than 1 week duration between symptom onset and admission to hospital (3·03 [1·68-5·48]). At 1 year after inclusion, of 432 children who were discharged alive from hospital with follow-up data, 24 (5%) had died, 129 (30%) had neurological sequelae, and 279 (65%) had completely recovered.</AbstractText><AbstractText Label="INTERPRETATION">In southeast Asia, most causes of childhood encephalitis are either preventable or treatable, with Japanese encephalitis virus being the most common cause. We provide crucial information that could guide public health policy to improve diagnostic, vaccination, and early therapeutic guidelines on childhood encephalitis in the Greater Mekong region.</AbstractText><AbstractText Label="FUNDING">Institut Pasteur, Institut Pasteur International Network, Fondation Merieux, Aviesan Sud, INSERM, Wellcome Trust, Institut de Recherche pour le Développement (IRD), and Fondation Total.</AbstractText><CopyrightInformation>Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pommier</LastName><ForeName>Jean David</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia; Institut Pasteur, Biology of Infection Unit, Paris, France; Inserm U1117, Paris, France; Intensive Care Department, University Hospital of Guadeloupe, Guadeloupe, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorman</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Virology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crabol</LastName><ForeName>Yoann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bleakley</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, CNRS, Inria, Laboratoire de Mathématiques d'Orsay, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sothy</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Kantha Bopha IV Children's Hospital, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santy</LastName><ForeName>Ky</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Kantha Bopha IV Children's Hospital, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Huong Thi Thu</ForeName><Initials>HTT</Initials><AffiliationInfo><Affiliation>National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Lam Van</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunnakea</LastName><ForeName>Em</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Kantha Bopha IV Children's Hospital, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hlaing</LastName><ForeName>Chaw Su</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Yangon Children's Hospital, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aye</LastName><ForeName>Aye Mya Min</ForeName><Initials>AMM</Initials><AffiliationInfo><Affiliation>Yangon Children's Hospital, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelle</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia; French Agricultural Research Centre for International Development (CIRAD), Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrant</LastName><ForeName>Magali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Department, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piola</LastName><ForeName>Patrice</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosset</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>French Agricultural Research Centre for International Development (CIRAD), Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Veronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia; French Agricultural Research Centre for International Development (CIRAD), Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantola</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Channa</LastName><ForeName>Mey</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Virology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honnorat</LastName><ForeName>Jerome</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>French Reference Center for Paraneoplastic Neurological Syndromes and Autoi mmune Encephalitis, Hospices Civils de Lyon, Synatac Team, NeuroMyoGene Institute, Inserm U1217/CNRS UMR5310, Université de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Anne Laure</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>French Reference Center for Paraneoplastic Neurological Syndromes and Autoi mmune Encephalitis, Hospices Civils de Lyon, Synatac Team, NeuroMyoGene Institute, Inserm U1217/CNRS UMR5310, Université de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattanavong</LastName><ForeName>Sayaphet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vongsouvath</LastName><ForeName>Manivanh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayxay</LastName><ForeName>Mayfong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Unité des Virus Émergents, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phangmanixay</LastName><ForeName>Sommanikhone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Children's Hospital, Vientiane, Laos.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phongsavath</LastName><ForeName>Khounthavy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Children's Hospital, Vientiane, Laos.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tin</LastName><ForeName>Ommar Swe</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>National Health Laboratory, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyaw</LastName><ForeName>Latt Latt</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>National Health Laboratory, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tin</LastName><ForeName>Htay Htay</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>National Health Laboratory, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linn</LastName><ForeName>Kyaw</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Yangon Children's Hospital, Yangon, Myanmar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Thi Mai Hung</ForeName><Initials>TMH</Initials><AffiliationInfo><Affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérot</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory for Pathogen Discovery, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thuy</LastName><ForeName>Nguyen Thi Thu</ForeName><Initials>NTT</Initials><AffiliationInfo><Affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hien</LastName><ForeName>Nguyen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Phuc Huu</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchy</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Virology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dussart</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Virology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurent</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kantha Bopha IV Children's Hospital, Phnom Penh, Cambodia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eloit</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for Pathogen Discovery, Institut Pasteur, Paris, France; Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubot-Pérès</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Unité des Virus Émergents, Marseille, France; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lortholary</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Université Paris Cité, Department of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, Institut Imagine, Assistance Publique-Hôpitaux de Paris, Paris, France; Institut Pasteur, CNRS, Molecular Mycology Unit, National Reference Center for Mycoses and Antifungals, UMR 2000, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lamballerie</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Unité des Virus Émergents, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Paul N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Lao-Oxford-Mahosot Hospital, Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lecuit</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Pasteur, Biology of Infection Unit, Paris, France; Inserm U1117, Paris, France; Université Paris Cité, Department of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, Institut Imagine, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: marc.lecuit@pasteur.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SEAe Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04089436</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Glob Health</MedlineTA><NlmUniqueID>101613665</NlmUniqueID><ISSNLinking>2214-109X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Glob Health. 2022 Jul;10(7):e934-e935. doi: 10.1016/S2214-109X(22)00208-X</RefSource><PMID Version="1">35714635</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050031" MajorTopicYN="Y">Hashimoto Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007812" MajorTopicYN="N" Type="Geographic">Laos</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests PB is currently an employee of GSK, this employment has no relation with the study presented here that was initiated at the time he was head of the virology unit at Pasteur Institute in Cambodia. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Buchy</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bunnakea</LastName><ForeName>Em</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappelle</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Channa</LastName><ForeName>Mey</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Veronique</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crabol</LastName><ForeName>Yoann</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Lamballerie</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubot-Pérès</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dussart</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eloit</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorman</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrant</LastName><ForeName>Magali</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hien</LastName><ForeName>Nguyen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hlaing</LastName><ForeName>Chaw Su</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Honnorat</LastName><ForeName>Jérôme</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hung</LastName><ForeName>Tran Thi Mai</ForeName><Initials>TTM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huong</LastName><ForeName>Tran Thi Thu</ForeName><Initials>TTT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kyaw</LastName><ForeName>Latt Latt</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lam</LastName><ForeName>Nguyen Van</ForeName><Initials>NV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laurent</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lecuit</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linn</LastName><ForeName>Kyaw</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lortholary</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayxay</LastName><ForeName>Mayfong</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Min Aye</LastName><ForeName>Aye Mya</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newton</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perot</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phangmanixay</LastName><ForeName>Sommanikhone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phongsavath</LastName><ForeName>Khounthavy</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phuc</LastName><ForeName>Phan Huu</ForeName><Initials>PH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Anne-Laurie</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piola</LastName><ForeName>Patrice</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pommier</LastName><ForeName>Jean-David</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rattanavong</LastName><ForeName>Sayaphet</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosset</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santy</LastName><ForeName>Ky</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sothy</LastName><ForeName>Heng</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tarantola</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thuy</LastName><ForeName>Nguyen Thi Thu</ForeName><Initials>NTT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tin</LastName><ForeName>Htay Htay</ForeName><Initials>HH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tin</LastName><ForeName>Ommar Swe</ForeName><Initials>OS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vongsouvath</LastName><ForeName>Manivanh</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>An</LastName><ForeName>Pham Nhat</ForeName><Initials>PN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anh</LastName><ForeName>Dang Duc</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Pascal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bun</LastName><ForeName>Kimrong</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chommanam</LastName><ForeName>Danoy</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davong</LastName><ForeName>Viengmon</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Debré</LastName><ForeName>Patrice</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delfraissy</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devaux</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douangnouvong</LastName><ForeName>Anousone</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duong</LastName><ForeName>Veasna</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Durand</LastName><ForeName>Benoit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eng</LastName><ForeName>Chanreaksmey</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrant</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fontenille</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hafner</LastName><ForeName>Lukas</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hai</LastName><ForeName>Le Thanh</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huong</LastName><ForeName>Do Thu</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jouan</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>July</LastName><ForeName>May</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lago</LastName><ForeName>Magali</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moatti</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murgue</LastName><ForeName>Bernadette</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oo</LastName><ForeName>Khin Yi</ForeName><Initials>KY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oum</LastName><ForeName>MengHeng</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phakhounthong</LastName><ForeName>Khansoudaphone</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pham</LastName><ForeName>Anh Tuan</ForeName><Initials>AT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quyen</LastName><ForeName>Do</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seephonelee</LastName><ForeName>Malee</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seguy</LastName><ForeName>Maud</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sibounheunang</LastName><ForeName>Bountoy</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sim</LastName><ForeName>Kanarith</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tan</LastName><ForeName>Luong Minh</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thair</LastName><ForeName>Cho</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thein</LastName><ForeName>Win</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thuy</LastName><ForeName>Phung Bich</ForeName><Initials>PB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tissot-Dupont</LastName><ForeName>Hervé</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vongsouvath</LastName><ForeName>Malavanh</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35714649</ArticleId><ArticleId IdType="pmc">PMC9210261</ArticleId><ArticleId IdType="doi">10.1016/S2214-109X(22)00174-7</ArticleId><ArticleId IdType="pii">S2214-109X(22)00174-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013;57:1114–1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783060</ArticleId><ArticleId IdType="pubmed">23861361</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Kohl KS, Bilynsky R, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5771–5792.</Citation><ArticleIdList><ArticleId IdType="pubmed">17570566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158385</ArticleId><ArticleId IdType="pubmed">21163445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailles A, De Broucker T, Costanzo P, Martinez-Almoyna L, Vaillant V, Stahl JP. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis. 2012;54:1455–1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">22460967</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler KL. Acute viral encephalitis. N Engl J Med. 2018;379:557–566.</Citation><ArticleIdList><ArticleId IdType="pubmed">30089069</ArticleId></ArticleIdList></Reference><Reference><Citation>Jmor F, Emsley HCA, Fischer M, Solomon T, Lewthwaite P. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol J. 2008;5:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583971</ArticleId><ArticleId IdType="pubmed">18973679</ArticleId></ArticleIdList></Reference><Reference><Citation>Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychol Rehabil. 2007;17:406–428.</Citation><ArticleIdList><ArticleId IdType="pubmed">17676528</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantola A, Goutard F, Newton P, et al. Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the Mekong region. PLoS Negl Trop Dis. 2014;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3907313</ArticleId><ArticleId IdType="pubmed">24498443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittrich S, Rattanavong S, Lee SJ, et al. Orientia, rickettsia, and leptospira pathogens as causes of CNS infections in Laos: a prospective study. Lancet Glob Health. 2015;3:e104–e112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547322</ArticleId><ArticleId IdType="pubmed">25617190</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Flavivirus encephalitis. N Engl J Med. 2004;351:370–378.</Citation><ArticleIdList><ArticleId IdType="pubmed">15269317</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936–942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Control of Japanese encephalitis—within our grasp? N Engl J Med. 2006;355:869–871.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailles A, Stahl J-P. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009;49:1838–1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">19929384</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Campbell AP, Supawat K, et al. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003–2005. Emerg Infect Dis. 2015;21:280–289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313633</ArticleId><ArticleId IdType="pubmed">25627940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai SC, Hacohen Y, Tantsis E, et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics. 2015;135:e974–e984.</Citation><ArticleIdList><ArticleId IdType="pubmed">25802349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Dang Trung N, Le Thi Phuong T, Wolbers M, et al. Aetiologies of central nervous system infection in Viet Nam: a prospective provincial hospital-based descriptive surveillance study. PLoS One. 2012;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360608</ArticleId><ArticleId IdType="pubmed">22662232</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565–1577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17109290</ArticleId></ArticleIdList></Reference><Reference><Citation>Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835–844.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L-P, Yuan Y, Liu Y-L, et al. Etiological and epidemiological features of acute meningitis or encephalitis in China: a nationwide active surveillance study. Lancet Reg Health West Pac. 2022;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743210</ArticleId><ArticleId IdType="pubmed">35036977</ArticleId></ArticleIdList></Reference><Reference><Citation>Granerod J, Tam CC, Crowcroft NS, Davies NWS, Borchert M, Thomas SL. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010;75:924–932.</Citation><ArticleIdList><ArticleId IdType="pubmed">20820004</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis. 2003;36:731–742.</Citation><ArticleIdList><ArticleId IdType="pubmed">12627357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam WK, Zhong NS, Tan WC. Overview on SARS in Asia and the world. Respirology. 2003;8(suppl):S2–S5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159403</ArticleId><ArticleId IdType="pubmed">15018125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta I, Guin P. Communicable diseases in the South-East Asia region of the World Health Organization: towards a more effective response. Bull World Health Organ. 2010;88:199–205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828785</ArticleId><ArticleId IdType="pubmed">20428387</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan NT, Gouilh MA, Paireau J, et al. Hypoglycemic toxins and enteroviruses as causes of outbreaks of acute encephalitis-like syndrome in children, Bac Giang province, northern Vietnam. Emerg Infect Dis. 2018;24:1435–1443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6056107</ArticleId><ArticleId IdType="pubmed">30014832</ArticleId></ArticleIdList></Reference><Reference><Citation>Desestret V, Chefdeville A, Viaccoz A, et al. CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2:e166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4630685</ArticleId><ArticleId IdType="pubmed">26568967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn MAAM, Bruijstens AL, Bastiaansen AEM, et al. Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm. 2020;7:e682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051211</ArticleId><ArticleId IdType="pubmed">32047077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewthwaite P, Begum A, Ooi MH, et al. Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ. 2010;88:584–592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908971</ArticleId><ArticleId IdType="pubmed">20680123</ArticleId></ArticleIdList></Reference><Reference><Citation>Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–118.</Citation><ArticleIdList><ArticleId IdType="pubmed">22039212</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723.</Citation></Reference><Reference><Citation>Horwood PF, Duong V, Laurent D, et al. Aetiology of acute meningoencephalitis in Cambodian children, 2010–2013. Emerg Microbes Infect. 2017;6:e35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520480</ArticleId><ArticleId IdType="pubmed">28536430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sili U, Kaya A, Mert A. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol. 2014;60:112–118.</Citation><ArticleIdList><ArticleId IdType="pubmed">24768322</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect. 2000;41:61–68.</Citation><ArticleIdList><ArticleId IdType="pubmed">10942642</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton PN, Dale RC, Blyth CC, et al. Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clin Infect Dis. 2020;70:2517–2526.</Citation><ArticleIdList><ArticleId IdType="pubmed">31549170</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabol Y, Pean P, Mey C, et al. A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections. Int J Infect Dis. 2017;59:69–76.</Citation><ArticleIdList><ArticleId IdType="pubmed">28438677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HS, Nguyen-Viet H, Lee M, Duc PP, Grace D. Seasonality of viral encephalitis and associated environmental risk factors in Son La and Thai Binh provinces in Vietnam from 2004 to 2013. Am J Trop Med Hyg. 2017;96:110–117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5239675</ArticleId><ArticleId IdType="pubmed">27799646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen NT, Duffy MR, Hong NM, Hein NT, Fisher M, Hills SL. Surveillance for Japanese encephalitis in Vietnam, 1998–2007. Am J Trop Med Hyg. 2010;83:816–819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946747</ArticleId><ArticleId IdType="pubmed">20889870</ArticleId></ArticleIdList></Reference><Reference><Citation>PATH  Loas launches national Japanese encephalitis vaccination campaign. April 1, 2015. https://www.path.org/media-center/laos-launches-national-japanese-encephalitis-vaccination-campaign</Citation></Reference><Reference><Citation>UNICEF  Japanese Encephalitis vaccine: market and supply update. October 2021. https://www.unicef.org/supply/media/10381/file/Japanese-Encephalitis-Vaccine-Supply-Demand-Update-October2021.pdf</Citation></Reference><Reference><Citation>WHO  Japanese encephalitis vaccination campaign achievement. https://www.who.int/myanmar/activities/japanese-encephalitis-vaccination-campaign-achievement</Citation></Reference><Reference><Citation>Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906–919.</Citation><ArticleIdList><ArticleId IdType="pubmed">23948177</ArticleId></ArticleIdList></Reference><Reference><Citation>A-Nuegoonpipat A, Panthuyosri N, Anantapreecha S, et al. Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. J Clin Virol. 2008;42:75–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">18304870</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantibhedhyangkul W, Angelakis E, Tongyoo N, et al. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. Int J Antimicrob Agents. 2010;35:338–341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610924</ArticleId><ArticleId IdType="pubmed">20138477</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CP, Busl KM. Neurologic manifestations of severe respiratory viral contagions. Crit Care Explor. 2020;2:e0107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188429</ArticleId><ArticleId IdType="pubmed">32426749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjalmarsson A, Blomqvist P, Brytting M, Linde A, Sköldenberg B. Encephalitis after influenza in Sweden 1987–1998: a rare complication of a common infection. Eur Neurol. 2009;61:289–294.</Citation><ArticleIdList><ArticleId IdType="pubmed">19295216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol. 2010;23:305–311.</Citation><ArticleIdList><ArticleId IdType="pubmed">20455276</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh H-L, Mohammad SS, Britton PN, et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol. 2016;73:300–307.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfopoulou S, Brown JR, Davies EG, et al. Human coronavirus OC43 associated with fatal encephalitis. N Engl J Med. 2016;375:497–498.</Citation><ArticleIdList><ArticleId IdType="pubmed">27518687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020;88:945–946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146652</ArticleId><ArticleId IdType="pubmed">32283294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna Huang Y, Jiang D, Huang JT. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun. 2020;87:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegazi MA, Mansor I, Rahman FA, El-Sayed M. Hepatitis A virus presenting as fatal encephalitis in a child. Pediatr Infect Dis J. 2011;30</Citation><ArticleIdList><ArticleId IdType="pubmed">21997663</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi MS, Tandale BV, Gore MM, et al. Evidence of hepatitis A virus infection in the patients with acute encephalitis syndrome in Gorakhpur region, North India. Acta Virol. 2018;62:208–213.</Citation><ArticleIdList><ArticleId IdType="pubmed">29895163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380:2327–2340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764751</ArticleId><ArticleId IdType="pubmed">31189036</ArticleId></ArticleIdList></Reference><Reference><Citation>Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54:899–904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297648</ArticleId><ArticleId IdType="pubmed">22281844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma BJ, Han W, Li J. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: a hospital-based prospective study. Brain Dev. 2020;42:179–184.</Citation><ArticleIdList><ArticleId IdType="pubmed">31563418</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840–851.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490181</ArticleId></ArticleIdList></Reference><Reference><Citation>Armangue T, Moris G, Cantarín-Extremera V, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. 2015;85:1736–1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653102</ArticleId><ArticleId IdType="pubmed">26491084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>